Concepedia

Holly Yin

HY

6

Publications

322

Citations

6

H-Index

2011

Active since

Affiliations

Translational Genomics Research Institute(Current)

Mayo Clinic in Arizona

Holly Yin is an author at Translational Genomics Research Institute specializing in cancer cell biology, cancer research, and gene expression.

Top concepts

Publications per year

2011–2024

6

Publications

6

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Yuan Xiao Zhu, Rodger E. Tiedemann, Chang-Xin Shi et al. · Blood · 2011 · 105 citations · Full text

A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters

Hyun-Jin Kang, Yunxi Cui, Holly Yin et al. · Journal of the American Chemical Society · 2016 · 103 citations · Full text

, , +20

Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells

Alison Roos, Harshil Dhruv, Ian T. Mathews et al. · Oncotarget · 2017 · 50 citations · Full text

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Lisa Evers, Pedro A. Pérez–Mancera, Elizabeth Lenkiewicz et al. · Genome Medicine · 2014 · 28 citations · Full text

Structural Basis and Targeting of the Interaction between Fibroblast Growth Factor-inducible 14 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis

Harshil Dhruv, Joseph C. Loftus, Pooja Narang et al. · Journal of Biological Chemistry · 2013 · 22 citations · Full text

Rows per page

1–5 of 6